About

Dr. Katie Mollan has 19 years of professional experience in clinical and public health research. She earned her PhD in Epidemiology at UNC Chapel Hill and has contributed to key areas of research on testing, prevention, and therapeutics for HIV, cervical cancer, Covid19, and Lassa fever. Dr. Mollan leads the statistical/epidemiologic design and analysis of clinical trials (phases II-IV) and longitudinal cohort studies (real world evidence) and mentors graduate-level trainees in collaborative research. Her research interests include comparative effectiveness, pharmacoepidemiology, applied causal inference (e.g., target trial emulation, transportability), infectious diseases, and mental health. Mollan has co-authored 80+ peer-reviewed articles, including first authorships in Annals of Internal Medicine, AJE, and CID. She has analyzed a broad range of clinical, laboratory, implementation, and patient-reported outcomes data. Mollan earned her M.S. in Statistics at the Ohio State University (2006) and worked at the Harvard T.H. Chan School of Public Health (2006-2012, AIDS Clinical Trials Group). Previously, Mollan co-led the UNC CFAR Biostatistics Core (2016-2020, Manager) and was founder of the UNC CFAR’s undergraduate internship program. Dr. Mollan served as a Statistical Editor for OFID (2014-2021) and currently is a voting member on a data safety monitoring board.